The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.


Journal

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628

Informations de publication

Date de publication:
07 2019
Historique:
received: 05 11 2018
accepted: 29 01 2019
pubmed: 5 2 2019
medline: 2 7 2020
entrez: 5 2 2019
Statut: ppublish

Résumé

Bone marrow (BM) is an essential source of hematopoietic stem cell grafts for many allogeneic hematopoietic cell transplant (HCT) recipients, including adult patients (for specific diseases and transplantation strategies) and the majority of pediatric recipient. However, since the advent of granulocyte colony-stimulating factor-mobilized peripheral blood stem cell (PBSC) grafts, there has been a significant decrease in the use of BM in HCT, thought to be due mainly to the increased logistical challenges in harvesting BM compared with PBSCs, as well as generally no significant survival advantage of BM over PBSCs. The decreased frequency of collection has the potential to impact the quality of BM harvests. In this study, we examined >15,000 BM donations collected at National Marrow Donor Program centers between 1994 and 2016 and found a significant decline in the quality of BM products, as defined by the concentration of total nucleated cells (TNCs). The mean TNC concentration in BM donations dropped from 21.8 × 10

Identifiants

pubmed: 30716454
pii: S1083-8791(19)30092-8
doi: 10.1016/j.bbmt.2019.01.034
pmc: PMC6615955
mid: NIHMS1522897
pii:
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1325-1330

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI145231
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA188523
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA076518
Pays : United States
Organisme : NHLBI NIH HHS
ID : U24 HL138660
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Références

Bone Marrow Transplant. 2008 Oct;42(7):443-7
pubmed: 18622419
Biol Blood Marrow Transplant. 2007 Dec;13(12):1461-8
pubmed: 18022576
Transfus Apher Sci. 2016 Oct;55(2):221-224
pubmed: 27452644
Eur J Haematol. 2017 Oct;99(4):357-365
pubmed: 28719093
Blood. 2005 Jan 15;105(2):548-51
pubmed: 15367429
Pediatr Transplant. 2017 Feb;21(1):
pubmed: 27813281
Biol Blood Marrow Transplant. 2015 Oct;21(10):1830-8
pubmed: 26116089
Pediatr Blood Cancer. 2011 Aug;57(2):224-6
pubmed: 21360660
Eur J Haematol. 2015 Nov;95(5):421-5
pubmed: 25645430
Int J Hematol. 2009 Mar;89(2):227-230
pubmed: 19130172
Hematology. 2014 Jan;19(1):1-9
pubmed: 23677141
Transfusion. 2016 May;56(5):1052-7
pubmed: 26898844
J Clin Oncol. 2017 Sep 10;35(26):3002-3009
pubmed: 28644773
Biol Blood Marrow Transplant. 2016 May;22(5):932-40
pubmed: 26797402
Crit Rev Oncol Hematol. 2015 May;94(2):179-88
pubmed: 25604498
Bone Marrow Transplant. 2015 Jul;50(7):1007-9
pubmed: 25893451
Pediatr Blood Cancer. 2013 Sep;60(9):1513-9
pubmed: 23512888
Blood. 2014 Jun 5;123(23):3655-63
pubmed: 24735965
Best Pract Res Clin Haematol. 2014 Sep-Dec;27(3-4):278-82
pubmed: 25455278
N Engl J Med. 2012 Oct 18;367(16):1487-96
pubmed: 23075175
Biol Blood Marrow Transplant. 2011 Mar;17(3):351-5
pubmed: 20553925

Auteurs

Nicole L Prokopishyn (NL)

Department of Pathology and Laboratory Medicine,University of Calgary, Calgary, Alberta, Canada.

Brent R Logan (BR)

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin.

Deidre M Kiefer (DM)

Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, Minnesota.

Jennifer A Sees (JA)

Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, Minnesota.

Pintip Chitphakdithai (P)

Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, Minnesota.

Ibrahim A Ahmed (IA)

Department of Hematology Oncology and Bone Marrow Transplantation, The Children's Mercy Hospitals and Clinics, Kansas City, Missouri.

Paolo N Anderlini (PN)

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.

Amer M Beitinjaneh (AM)

Department of Hematology, University of Miami, Miami, Florida.

Christopher Bredeson (C)

The Ottawa Hospital Blood and Marrow Transplant Program and the Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Jan Cerny (J)

Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts.

Saurabh Chhabra (S)

Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

Andrew Daly (A)

Tom Baker Cancer Center, Calgary, Alberta, Canada.

Miguel Angel Diaz (MA)

Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.

Nosha Farhadfar (N)

Division of Hematology/Oncology, University Florida College of Medicine, Gainesville, Florida.

Haydar A Frangoul (HA)

Division of Pediatric-Hematology and Oncology, The Children's Hospital at TriStar Centennial and Sarah Cannon Research Institute, Nashville, Tennessee.

Siddhartha Ganguly (S)

Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.

Dennis A Gastineau (DA)

Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota.

Usama Gergis (U)

Hematolgic Malignancies & Bone Marrow Transplant, Department of Medical Oncology, New York Presbyterian Hospital/Weill Cornell Medical College, New York, New York.

Gregory A Hale (GA)

Department of Hematology/Oncology, Johns Hopkins All Children's Hospital, St. Petersburg, Florida.

Peiman Hematti (P)

Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.

Rammurti T Kamble (RT)

Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.

Kimberly A Kasow (KA)

Department of Pediatrics in the Division of Hematology-Oncology, University of North Carolina, Chapel Hill, North Carolina.

Hillard M Lazarus (HM)

Seidman Cancer Center-University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Jane L Liesveld (JL)

Strong Memorial Hospital-University of Rochester Medical Center, Rochester, New York.

Hemant S Murthy (HS)

Division of Hematology/Oncology, University Florida College of Medicine, Gainesville, Florida.

Maxim Norkin (M)

Division of Hematology/Oncology, University Florida College of Medicine, Gainesville, Florida.

Richard F Olsson (RF)

Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.

Mona Papari (M)

ITxM Clinical Services Cord Blood Lab, Rosemont, Illinois.

Bipin N Savani (BN)

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Jeffrey Szer (J)

Clinical Haematology at Peter MacCalluma Cancer Centre and The Royal Melbourne Hospital, Victoria, Australia.

Edmund K Waller (EK)

Department of Hematology and Meidcal Oncology, Emory University Hospital, Atlanta, Georgia.

Baldeep Wirk (B)

Division of Bone Marrow Transplant, Seattle Cancer Care Alliance, Seattle, Washington.

Jean A Yared (JA)

Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland.

Michael A Pulsipher (MA)

Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, California.

Nirali N Shah (NN)

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Galen E Switzer (GE)

Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.

Paul V O'Donnell (PV)

Department of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Dennis L Confer (DL)

Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, Minnesota; National Marrow Donor Program/Be The Match, Minneapolis, Minnesota.

Bronwen E Shaw (BE)

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: beshaw@mcw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH